TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 2 | 0 | 0 | -3 | 11 | -22 | -37 | -13 |
S | %wins | 100 | 50 | 100 | 50 | 50 | 100 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/16/12 17:05 | 11/15/12 | CPIX | Cumberland Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Marstiller Jean W | TN | O | SVP,Corp | M.d | 1 | 3.50 | 0 | 0 | 0 | 441 | D | -33 | -23 | -34 | -25 | -28 | -27 | -23 | -2 | 0 | -3 | -5 | -3 | 7 | 8 | |
11/22/11 17:21 | 11/21/11 | CPIX | Cumberland Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Marstiller Jean W | TN | O | SVP,Corp | S.d | -15 | 5.73 | 0 | -3 | -1 | 437 | D | -62 | -17 | 16 | 1 | 1 | 2 | 2 | 5 | 0 | -1 | -4 | 32 | 2 | -27 | |
11/22/11 17:21 | 11/21/11 | CPIX | Cumberland Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Marstiller Jean W | TN | O | SVP,Corp | M.d | 15 | 1.63 | 0 | 9 | 2 | 437 | D | -62 | -17 | 16 | 1 | 1 | 2 | 2 | 5 | 0 | -1 | -4 | 32 | 2 | -27 | |
2/9/10 20:50 | 2/7/10 | CPIX | Cumberland Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Marstiller Jean W | TN | O | SVP,Corp | S | -1,829 | 11.91 | 0 | -154 | -26 | 428 | D | -9 | -19 | -17 | -7 | -7 | 0 | 1 | -2 | -10 | -45 | -47 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |